Compare Aurobindo Pharma with THEMIS MEDICARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs THEMIS MEDICARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA THEMIS MEDICARE AUROBINDO PHARMA/
THEMIS MEDICARE
 
P/E (TTM) x 7.6 15.0 50.2% View Chart
P/BV x 1.8 3.9 46.3% View Chart
Dividend Yield % 0.6 0.5 127.4%  

Financials

 AUROBINDO PHARMA   THEMIS MEDICARE
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
THEMIS MEDICARE
Mar-21
AUROBINDO PHARMA/
THEMIS MEDICARE
5-Yr Chart
Click to enlarge
High Rs1,023424 241.3%   
Low Rs333232 143.7%   
Sales per share (Unadj.) Rs422.8251.0 168.5%  
Earnings per share (Unadj.) Rs92.028.5 322.3%  
Cash flow per share (Unadj.) Rs110.037.8 290.7%  
Dividends per share (Unadj.) Rs4.004.30 93.0%  
Avg Dividend yield %0.61.3 45.0%  
Book value per share (Unadj.) Rs374.3237.4 157.7%  
Shares outstanding (eoy) m585.949.19 6,375.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.61.3 122.8%   
Avg P/E ratio x7.411.5 64.2%  
P/CF ratio (eoy) x6.28.7 71.2%  
Price / Book Value ratio x1.81.4 131.2%  
Dividend payout %4.315.1 28.9%   
Avg Mkt Cap Rs m397,3983,014 13,186.5%   
No. of employees `000NANA-   
Total wages/salary Rs m35,350400 8,839.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m247,7462,307 10,740.3%  
Other income Rs m3,80936 10,514.9%   
Total revenues Rs m251,5552,343 10,736.8%   
Gross profit Rs m81,480495 16,462.6%  
Depreciation Rs m10,55485 12,348.1%   
Interest Rs m745127 585.9%   
Profit before tax Rs m73,990319 23,226.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,09856 35,710.2%   
Profit after tax Rs m53,892262 20,547.4%  
Gross profit margin %32.921.5 153.3%  
Effective tax rate %27.217.7 153.8%   
Net profit margin %21.811.4 191.3%  
BALANCE SHEET DATA
Current assets Rs m198,2351,855 10,688.3%   
Current liabilities Rs m106,6521,283 8,312.3%   
Net working cap to sales %37.024.8 149.2%  
Current ratio x1.91.4 128.6%  
Inventory Days Days1979 24.2%  
Debtors Days Days521,228 4.2%  
Net fixed assets Rs m135,7781,857 7,312.8%   
Share capital Rs m58692 637.6%   
"Free" reserves Rs m218,7132,090 10,467.1%   
Net worth Rs m219,2992,181 10,053.1%   
Long term debt Rs m1,684222 758.7%   
Total assets Rs m334,0133,711 8,999.7%  
Interest coverage x100.33.5 2,861.8%   
Debt to equity ratio x00.1 7.5%  
Sales to assets ratio x0.70.6 119.3%   
Return on assets %16.410.5 155.9%  
Return on equity %24.612.0 204.4%  
Return on capital %33.818.5 182.4%  
Exports to sales %53.843.1 124.7%   
Imports to sales %16.40-   
Exports (fob) Rs m133,248995 13,392.7%   
Imports (cif) Rs m40,615NA-   
Fx inflow Rs m133,248995 13,392.7%   
Fx outflow Rs m44,94627 165,119.8%   
Net fx Rs m88,302968 9,124.9%   
CASH FLOW
From Operations Rs m33,289570 5,842.8%  
From Investments Rs m5,987-157 -3,825.3%  
From Financial Activity Rs m-13,648-256 5,321.5%  
Net Cashflow Rs m25,831157 16,476.9%  

Share Holding

Indian Promoters % 48.8 57.6 84.7%  
Foreign collaborators % 3.1 9.6 31.9%  
Indian inst/Mut Fund % 37.2 0.0 372,300.0%  
FIIs % 21.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 32.8 146.8%  
Shareholders   329,940 6,511 5,067.4%  
Pledged promoter(s) holding % 24.4 27.4 89.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA  SAKAR HEALTHCARE   LINCOLN PHAR  VIVIMED LABS  ROOPA INDUSTRIES  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

THEMIS MEDICARE 2020-21 Annual Report Analysis (Annual Result Update)

Nov 3, 2021 | Updated on Nov 3, 2021

Here's an analysis of the annual report of THEMIS MEDICARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of THEMIS MEDICARE. Also includes updates on the valuation of THEMIS MEDICARE.

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Nov 26, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS